Journal of Nepal Medical Association (Jul 2003)

Ifosfamide-Induced Irreversible Encephalopathy

  • H Zhang,
  • J Dong,
  • Y Wang,
  • SK Singh

DOI
https://doi.org/10.31729/jnma.639
Journal volume & issue
Vol. 42, no. 148

Abstract

Read online

Ifosfamide associated central nervous system toxicity has been reported in 5% to 30%of patients treated with ifosfamide. Death from irreversible encephalopathy has been reported rarely. A 52-year-old lady with carcinoma of cervix was treated with concurrent chemo-Radiatherapy, and residual disease was given with new adjuvant chemotherapy, containing regimens ifosfamide and cisplatin. Two days after the initiation of ifosfamide, the patient exhibited onset of lethal encephalopathy manifested by subacutely progressive encephlopathy then to a vegetative state and eventually to death. Brain CT-scan showed no metastatic tumor and vascular cause, blood routine examination for infection and metabolic factors was also negative; except Urea and Creatinine was increasing. Ifosfamide is known to be capable of causing acute encephalopathy that can be severe but is generally reversible. This lady showed a very atypical progressive, lethal course of ifosfamide toxicity. The possibility of this complication should be considered when kidney function is within normal limits. Key Words: ifosfamide, encephalopathy.